Tofogliflozin-impurities | Pharmaffiliates

tofogliflozin

Tofogliflozin, a novel and selective SGLT2 inhibitor improves glycemic control and lowers body weight in patients with type 2 diabetes mellitus inadequately. Reference standards of Tofogliflozin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Tofogliflozin-d5
    [catalogue_number] => PA STI 083570
    [category_ids] => ,80,71,81,78,70,82,98,
    [chemical_name] => 
    [weight] => 391.47
    [form] => C22H21D5O6
    [cas] => NA
    [pslug] => tofogliflozin-d5-pasti083570
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 083570

Tofogliflozin-d5


  • Catalogue No.:PA STI 083570

  • CAS :

    NA

  • Molecular Formula : C22H21D5O6

  • Molecular Weight : 391.47